An official website of the United States government
Here's how you know
Official websites use .mil
A
.mil
website belongs to an official U.S. Department of Defense organization in the United States.
Secure .mil websites use HTTPS
A
lock (
lock
)
or
https://
means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.
Skip to main content (Press Enter).
Toggle navigation
JPEO-CBRND
Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense
JPEO-CBRND
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Search
Search Joint Program Executive Office for Chemical, Biological Defense (JPEO-CBRND):
Search
Home
About
Leadership
Joint Project Managers & Joint Project Leads
Our Story
Resources
Media
News
Photography
Work With Us
JETT - Joint Enterprise Technology Tool
SPARK
Careers
Contact
News
Results:
Archive:
March, 2020
DOD-Funded Diagnostic Test for COVID-19 Granted Emergency Use Authorization
March 31, 2020
— JPEO-CBRND’s industry partner BioFire Defense, LLC is producing COVID-19 tests to aid in pandemic response...
MORE
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
March 24, 2020
— ALACHUA, Fla. & PLYMOUTH MEETING, Pa.--March 24, 2020--Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), and Inovio Pharmaceuticals Inc., (NASDAQ: INO) developing DNA medicines for infectious diseases and cancer, announced today that the Department of Defense (DOD) has awarded Ology Bioservices with a...
MORE
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoclonal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
March 23, 2020
— ALACHUA, Fla. – March 23, 2020 – The Department of Defense (DOD) awarded a contract valued at $14 million with Ology Bioservices Inc., a biologics contract development and manufacturing organization (CDMO), to develop and manufacture a monoclonal antibody for treatment and prevention of infection with the COVID-19 virus. This work is supported...
MORE
DOD Leveraging Diagnostic Platform for COVID-19 Rapid Response
March 11, 2020
— JPEO-CBRND’s JPM CBRN Medical facilitated use of existing contract capabilities to address the global coronavirus threat...
MORE
News Search
News Archive - Search by Year and Month
2024 (34)
2023 (36)
2022 (31)
2021 (37)
2020 (15)
December (3)
November (1)
August (1)
July (3)
May (1)
April (1)
March (4)
February (1)
2019 (11)
2018 (5)
2017 (9)
2016 (1)
JPEO-CBRND Press Kit
Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.
JPEO-CBRND Public Affairs Office
The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.